July 2020
Assessment of Veliparib Treatment for Ovarian Cancer Types
August 07, 2020
Article
Directions in Pharmacy
Several recent studies presented at the virtual SGO 2020 Annual Meeting on Women’s Cancer looked into veliparib, a potential anticancer PARP inhibitor, for treatment of various types of ovarian cancer.
Study Results Find Teclistamab Has Manageable Safety Across All Doses Explored
August 07, 2020
Article
Directions in Pharmacy
The clinical trial of teclistamab sought to identify a recommended phase 2 dose for patients with RRMM, with multiple IV doses and priming doses explored.
Investigators Analyze Neutropenia During Venetoclax Monotherapy in Patients With R/R CLL
August 06, 2020
Article
Directions in Pharmacy
A recent study evaluated the efficacy of venetoclax monotherapy in participants with relapsed or refractory chronic lymphocytic leukemia.
Brown Bag Consult®: Patients With Multiple Myeloma Need Support Throughout Challenging Time
August 01, 2020
Article
Directions in Pharmacy
As the most accessible member of the health care team, the pharmacist can provide patients with cancer with the information and support necessary to get through what might be the most challenging time of their lives.
Experts Discuss Treatment Advances for Chronic Lymphocytic Leukemia
July 31, 2020
Article
Directions in Pharmacy
“These new therapies allow for treatment without some of the traditional chemotherapy agents.”
Study: Cemiplimab Shows Clinically Significant Responses in Second-Line Advanced Basal Cell Carcinoma
July 31, 2020
Article
Directions in Pharmacy
A fully human monoclonal antibody, cemiplimab targets the immune checkpoint receptor PD-1 on T cells, blocking cancer cells from using the PD-1 pathway to suppress T-cell activation.
A New Monoclonal Antibody for R/R MM: Isatuximab-irfc
July 30, 2020
Article
Directions in Pharmacy
Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Rare Pharmacy Emerges From Specialty: Part 1
July 30, 2020
Article
Directions in Pharmacy
The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.
Combination Therapy Demonstrates Promising Antitumor Activity
July 29, 2020
Article
Directions in Pharmacy
These study results were announced by Eisai and Merck during the 2020 American Society of Clinical Oncology Virtual Scientific Program, May 29-31.
How Specialty Pharmacies Can Improve Transitional Care Amid COVID-19
July 29, 2020
Article
Directions in Pharmacy
As clinicians, we must first understand the unique challenges that a patient is facing and then tailor our support to address their specific needs.
Value-Based Oncology Care Offers Clinical Opportunities for Pharmacists
July 29, 2020
Article
Directions in Pharmacy
Pharmacists can deliver value-based oncology services as an integral part of the health care team to improve patient outcomes.
An Overview of Epithelioid Sarcoma
July 29, 2020
Article
Directions in Pharmacy
Sarcomas account for about 1% of all adult cancers and 15% of all pediatric cancers.
Why Generics Matter More Than Ever Before in Today’s Specialty Pharmacies
July 28, 2020
Article
Directions in Pharmacy
Many pharmacies may be missing significant, profitable opportunities...via generic pharmaceuticals.
Researchers Analyze Neutropenia During Venetoclax Monotherapy in Patients With R/R CLL
July 28, 2020
Article
Directions in Pharmacy
The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast Cancer
July 27, 2020
Article
Directions in Pharmacy
Following initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
Securing Specialty Oncology Contracts in a Data-Driven World
July 26, 2020
Article
Directions in Pharmacy
Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Value-Based Contracting in Oncology
July 25, 2020
Article
Directions in Pharmacy
Meaningful breakthrough therapies are receiving accelerated approval based on evidence of impact on a surrogate end point rather than evidence of impact on the actual clinical benefit for which the drug is intended.
Pharmacist Management of Alpelisib-Associated Hyperglycemia
July 23, 2020
Article
Directions in Pharmacy
The selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.
Study: Patients With Cancer and COVID-19 Experience Higher Mortality
July 19, 2020
Article
Directions in Pharmacy
Results of the COVID-19 and Cancer Consortium cohort study were presented during the 2020 American Society of Clinical Virtual Scientific Program.
Overcoming Challenges to Meet the Needs of Patients and Pharmacists
July 18, 2020
Article
Directions in Pharmacy
Directions in Oncology PharmacyTM provides insight into how specialty pharmacies can improve transitional care during the COVID-19 pandemic.